
Metformin Tablets
Type 2 Diabetes Mellitus
500mg · 850mg
Metformin tablets for type 2 diabetes. It reduces sugar output from the liver and helps the body respond better to its own insulin.
Metformin (Glucovance) is a biguanide medicine for type 2 diabetes mellitus, available across 8 products in this catalogue, including Glucophage Trio, Jentadueto Xr and 6 more.

Type 2 Diabetes Mellitus
500mg · 850mg
Metformin tablets for type 2 diabetes. It reduces sugar output from the liver and helps the body respond better to its own insulin.

Type 2 Diabetes Mellitus
2.5mg + 400mg · 5mg + 500mg
Metformin and glibenclamide tablets for type 2 diabetes. The two drugs lower blood sugar by different routes, so one pill does the work of two separate ones.

Type 2 Diabetes Mellitus
5mg + 1000mg
A linagliptin and metformin tablet for type 2 diabetes. Metformin cuts liver glucose output; linagliptin boosts insulin release after meals.

Type 2 Diabetes Mellitus
15mg + 500mg
Pioglitazone and metformin tablets for type 2 diabetes. The two ingredients work on different aspects of blood sugar control.

Type 2 Diabetes Mellitus
1mg + 0.2mg + 500mg
Glimepiride and metformin tablets for type 2 diabetes. Glimepiride triggers insulin release, metformin cuts the liver's sugar output.

Type 2 Diabetes Mellitus
2.5mg + 500mg
Linagliptin and metformin tablets for type 2 diabetes. The linagliptin part does not need dose adjustment in kidney disease.
Metformin is used alongside diet and exercise to improve blood sugar control in adults and children aged 10 and older with Type 2 Diabetes Mellitus. The label positions it as an adjunct to these lifestyle measures, not a replacement for them.
Metformin is sold under several brand names in this catalogue. Glucovance and Metaglip come from Bristol-Myers Squibb, Jentadueto and Jentadueto Xr from Boehringer Ingelheim, Actoplus Met from Takeda, and Glucophage Trio and Istamet from Merck. The combination products pair metformin with a second glucose-lowering ingredient from a range of classes: sulfonylureas such as glibenclamide, glimepiride or glipizide; DPP-4 inhibitors such as linagliptin or sitagliptin; the thiazolidinedione pioglitazone; or the alpha-glucosidase inhibitor voglibose. All eight products are tablets, part of the Diabetes Management category.

5 Aug 2026 ⋅ 9 min read
Fasting changes when you take most medicines, not whether you need them. What to raise with your doctor before Ramadan, which medicines carry real risk during a fast, and why stopping a chronic medicine quietly is the dangerous option.
Read guide
5 Aug 2026 ⋅ 9 min read
Type 2 diabetes symptoms can be mild enough to go unnoticed for years, so it is often diagnosed after complications have already started. What to watch for, what the treatments do, and why more than half of people with diabetes take no medication for it.
Read guide
29 Jul 2026 ⋅ 8 min read
Most medicines are licensed to be stored below 25°C, and a UAE summer runs well past that. Which medicines fail first in the heat, which ones make heat itself riskier, and what to do about deliveries, cars and travel.
Read guide